Home > Insider Trading > Filing (0001209191-21-027460)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1664106	Logicbio Therapeutics Inc.	LOGC	Biological Products, (No Disgnostic Substances) (2836)	471514975

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1831341	Kyle Chiang	C/O Logicbio Therapeutics, Inc. 65 Hayden Ave, Floor 2 Lexington MA 02421	Chief Operating Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-04-15	9,360	$0.00	26,364	No	4	M	Direct
Common Stock	Disposition	2021-04-16	2,977	$5.73	23,387	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2021-04-15	9,360	$0.00	9,360	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	M	Direct

Footnotes

Each restricted stock unit ("RSU") represented a contingent right to receive one share of common stock of LogicBio Therapeutics, Inc. (the "Company").
Relates to shares sold at a weighted average price of $5.73 per share to cover tax withholding obligations in connection with the vesting of RSUs. Shares were sold in multiple transactions at prices ranging from $5.68 to $5.89, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
All of the RSUs vested on April 15, 2021, subject to the terms and conditions of the award and the Company's 2018 Equity Incentive Plan.